Oxford Asset Management’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-650
| Closed | -$210K | – | 2121 |
|
|
2019
Q3 | $210K | Sell |
650
-305
| -32% | -$98.5K | 0.01% | 1561 |
|
|
2019
Q2 | $412K | Buy |
955
+481
| +101% | +$208K | 0.01% | 1344 |
|
|
2019
Q1 | $268K | Buy |
+474
| New | +$268K | 0.01% | 1434 |
|
|
2018
Q3 | – | Sell |
-227
| Closed | -$131K | – | 1945 |
|
|
2018
Q2 | $131K | Sell |
227
-1,414
| -86% | -$816K | ﹤0.01% | 1624 |
|
|
2018
Q1 | $4.44M | Buy |
+1,641
| New | +$4.44M | 0.09% | 219 |
|